Stay updated on Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, a minor internal versioning change without affecting page content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:59:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1; no visible changes to study details or layout.
    Difference
    0.0%
    Check dated 2026-02-06T09:11:24.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Minor UI/text changes were made: added glossary toggle labels (Show glossary / Hide glossary), capitalization tweaks for QC criteria and FEAR Act data labels, and the page revision updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-22T17:37:54.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.4 added and Revision: v3.3.3 removed, a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T10:40:59.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The study's Locations section was updated, introducing numerous new sites across the United States and other countries, and removing several existing location groupings. The revision is labeled v3.3.3.
    Difference
    2%
    Check dated 2025-12-17T19:54:02.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new publication citation was added to the Publications section: Ajani et al., Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma, Adv Ther. 2025 (Online ahead of print). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-10T19:11:27.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.